Special Issue on Spatial Omics
Rong Fan, PhD
Omer Bayraktar, PhD
Wellcome Sanger Institute
Single-cell omics has revolutionized biological and biomedical research in the past decade despite the inability to measure single cells in the tissue context. Spatial omics, which allows for profiling a range of biomolecules with high spatial resolution across the central dogma of molecular biology directly in the tissue context, not only offers spatial information but unlocks unprecedented new opportunities to delve into clinical specimens for human biology research, therapeutic discovery, and translational medicine. Spatial omics is becoming one of the fastest-paced growth areas in the biotech industry and poised to drive the next wave of biology revolution with widespread and far-reaching impact in all major fields of life science and medicine.
GEN Biotechnology is pleased to announce a call for papers for our inaugural special issue: Spatial Omics.
This collection of research articles, reviews, and perspectives will be published in late 2023. We invite researchers to submit without delay manuscripts describing original research on any aspect of spatial omics technology and biological research. We will also consider relevant guest commentaries and review articles.
Specific topics may include (but are not confined to):
- Sequencing based spatial omics (i.e., transcriptome, proteome, epigenome, and genome).
- High-plex imaging of proteins, transcripts, or epigenomic/genomic features
- Spatial proteomics and metabolomics
- Spatial multi-omics and multi-modality tissue profiling
- Computational methods and tools for spatial biology (machine learning, data deconvolution, mathematical modeling, data visualization)
- Spatial omics to profile tumor heterogeneity and microenvironments
- Spatial omics in neuroscience, neurological or neurodegenerative disease research
- Spatial omics in aging, senescence, metabolic and chronic diseases.
Manuscripts will receive prompt peer review and accepted articles will be published rapidly online ahead-of-print. Please refer to our Instructions for Authors before submitting your manuscript.
Benefits of publishing in GEN Biotechnology include:
- Average time to first decision: 18 days
- Expert peer review and editorial oversight of your manuscript from leading specialists in your field
- Zero embargo green open access
- Free 30-day access to share your published research with your networks and colleagues
- Global visibility in more than 170 countries worldwide
- Open access options available